Hirokazu Kanegane, Prof.MD, PhD 1, Kohsuke Imai, Prof.MD, PhD 2, Masafumi Yamada, Prof.MD, PhD 3, Hidetoshi Takada, Prof.MD, PhD 4, Tadashi Ariga, Prof.MD, PhD 3, Ataru Igarashi, Prof.PhD 5, Kiichiro Tsutani, Prof.MD, PhD 5, Martin Bexon, Dr.MD 6, Mikhail Rojavin, Dr.PhD 7, Midori Kobayashi, Ms.BSPharm, MBA 8, John-Philip Lawo, Dr.PhD 9, Art Zbrozek, Mr.RPh, MSc, MBA 10, Shigeaki Nonoyama, Prof.MD, PhD 11, Toshiro Hara, Prof.MD, PhD 4, Toshio Miyawaki, Prof.MD, PhD 1
1 Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
2 Department of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University, Tokyo, Japan
3 Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
4 Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
5 Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
6 Clinical Research and Development, CSL Behring AG, Berne, Switzerland
7 Clinical Research and Development, CSL Behring LLC, King of Prussia, PA
8 Research and Development, CSL Behring K.K., Tokyo, Japan
9 CSL Behring GmbH, Marburg, Germany
10 CSL Behring LLC, King of Prussia, PA
11 Department of Pediatrics, National Defense Medical College, Tokorozawa, Japan